P19-29. Determining the optimal protocol for plasmid DNA vaccine delivery by intradermal <it>in vivo </it>electroporation by Nihlmark K, Gelius E, Roos A, Bråve A, Hallengärd D, Wahren B

Do circulating HIV vaccine plasmids contribute to immunogenicity in humans? by Albert J, Sandström E, Gudmundsdotter L, Aperia K, Engström G, Wahren B, Bråve A

P14-14 LB. A low dose of multigene, multiclade HIV DNA given intradermally induces strong and broad immune responses after boosting with heterologous HIV MVA by Wahren B, Moss B, Earl P, Michael N, Marovich M, Robb M, Brave A, Hejdeman B, Stout R, Mwanyika L, Mbwana J, Janabi M, Lyamuya E, Aris EA, Moshiro C, Buma D, Francis J, Nilsson C, Aboud S, Bakari M, Biberfeld G, Pallangyo K, Mhalu F, Sandstrom E